Perindopril reverses myocyte remodeling in the hypertensive heart

Hypertension Research

Volumn 25, Issue 1, 2002, Pages 85-90

  Onodera, Tatsuyuki ^a   Okazaki, Fumiko ^a   Miyazaki, Hidekazu ^a   Minami, Shunrou ^a   Ito, Takashi ^a   Seki, Shingo ^a   Taniguchi, Masayuki ^a   Taniguchi, Ikuo ^a   Mochizuki, Seibu ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

blockade; ACE inhibitor; Hypertension; Myocyte remodeling

Indexed keywords

BISOPROLOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CELL SIZE; CELL STRUCTURE; CELL VOLUME; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; HYPERTENSION; NONHUMAN; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BISOPROLOL; CELL COUNT; CELL SIZE; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; FEMALE; HEART; HYPERTENSION; MYOCARDIUM; PERINDOPRIL; RATS; RATS, INBRED SHR; VENTRICULAR REMODELING;

EID: 0036185348     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.25.85     Document Type: Article

References (30)

1. Wall stress and patterns of hypertrophy in the human left ventricle
2. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
3. Prognostic significance of serial changes in left ventricular mass in essential hypertension
4. Myocyte remodeling during the progression to failure in rats with hypertension
5. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats
6. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term
7. Antihypertensive action of the converting enzyme inhibitor perindopril (S9490-3) in spontaneously hypertensive rats: Comparison with enarapril (MK421) and ramipril (HOE498)
8. Long-term beta-blocker treatment prevents chronic creatine kinase and lactate dehydrogenase system changes in rat hearts after myocardial infarction
9. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy: Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure
10. Morphometric study of cardiac muscle: The problem of tissue shrinkage
11. The influence of aging and growth on the postnatal development of cardiac muscle in rats
12. Some statistical methods useful in circulation research
13. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
14. Reversal of left ventricular hypertrophy in hypertensive patients: A metaanalysis of 109 treatment studies
15. Molecular characterization of angiotensin II induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: Critical role of the AT1 receptor subtype
16. Maladaptive remodeling of cardiac myocyte shape begins long before failure in hypertension
17. Clinical efficacy of perindopril in hypertension
18. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats
19. The angiotensin-converting enzyme inhibitor, perindopril, prevents cardiac hypertrophy in low-renin hypertensive rats
20. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension
21. Ventricular wall stress revisited, a key stone of cardiology
22. Lisinopril reduces left ventricular hypertrophy and cardiac polyamine concentrations without a reduction in left ventricular wall stress in transgenic tsukuba hypertensive mice
23. Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats
24. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro
25. Reverse remodeling of cardiac myocyte hypertrophy in hypertension and failure by targeting of the renin-angiotensin system
26. Time course of regression of left ventricular hypertrophy in hypertensive patients treated with atenolol
27. Possible regression of left ventricular hypertrophy during antihypertensive treatment with diuretics and/or beta blockers
28. Development of SHR hypertension and cardiac hypertrophy during prolonged beta blockade
29. The effects of beta adrenoreceptor blockade with atenolol on myocardial cellular and subcellular hypertrophy in spontaneously hypertensive rats
30. Left ventricular hypertrophy in hypertension: Stimuli, patterns, and consequences